Login / Signup

Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA).

Guillaume MansonCharles HerbauxJean-Marc SchianoOlivier CasasnovasAspassia StamatoullasBenedicte DeauAnna SchmittCaroline RegnyKrimo BouabdallahAdrien ChauchetHervé GhesquièresAdrian TempesculRemy DuleryEmmanuelle Nicolas-VirelizierAlain Jacques DelmerCecile BorelLaurent DerclePauline BriceRoch Houotnull null
Published in: British journal of haematology (2022)
Keyphrases
  • hodgkin lymphoma
  • quality improvement
  • free survival